FDA to Review Egalet's (EGLT) Prior Approval Supplement (PAS) by June 17th for OXAYDO in Management of Acute and Chronic Moderate to Severe Pain

Source Link:

http://egalet.investorroom.com/2017-04-18-Egalet-Announces-U-S-Food-and-Drug-Administration-Acceptance-of-File-for-Prior-Approval-Supplement-for-OXAYDO-R-oxycodone-HCl-USP-tablets-C-II-10-mg-and-15-mg-Dosage-Strengths